Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration

Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate

(2018) Kazuya Toriumi et al.   BEHAVIOURAL BRAIN RESEARCH

Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801

(2016) A M Bygrave et al.   Translational Psychiatry

Neonatal Administration of Memantine Enhances Social Cognition in Adult Rats Subjected to Early Maternal Deprivation

(2016) Ezequiel Uribe et al.   Experimental Neurobiology

NMDA receptor dysfunction in autism spectrum disorders

(2015) Eun-Jae Lee et al.   CURRENT OPINION IN PHARMACOLOGY

NMDA receptor activation regulates sociability by its effect on mTOR signaling activity

(2015) Jessica A. Burket et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Acute administration of MK-801 in an animal model of psychosis in rats interferes with cognitively demanding forms of behavioral flexibility on a rotating arena

(2015) Jan Svoboda et al.   Frontiers in Behavioral Neuroscience

New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences

(2015) Olga Peñagarikano   Experimental Neurobiology

Exploring the Validity of Valproic Acid Animal Model of Autism

(2015) Darine Froy N. Mabunga et al.   Experimental Neurobiology

Subchronic Treatment of Donepezil Rescues Impaired Social, Hyperactive, and Stereotypic Behavior in Valproic Acid-Induced Animal Model of Autism

(2014) Ji-Woon Kim et al.   PLoS One

Pharmacological disruption of mouse social approach behavior: Relevance to negative symptoms of schizophrenia

(2013) Ashley N. Hanks et al.   BEHAVIOURAL BRAIN RESEARCH

GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice

(2013) P S Suryavanshi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

(2013) Harvey A Whiteford et al.   LANCET

An updated overview of animal models in neuropsychiatry

(2013) M. Razafsha et al.   NEUROSCIENCE

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

(2013) Andrea de Bartolomeis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Impaired cliff avoidance reaction in dopamine transporter knockout mice

(2013) Motoyasu Yamashita et al.   PSYCHOPHARMACOLOGY

Citrus flavonoid improves MK-801-induced locomotive hyperactivity: Possible relevance to schizophrenia

(2013) Satoshi Okuyama et al.   Journal of Functional Foods

Memantine Reverses Social Withdrawal Induced by Ketamine in Rats

(2013) Ezequiel Uribe et al.   Experimental Neurobiology

NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders

(2012) John A. Saunders et al.   BEHAVIOURAL BRAIN RESEARCH

Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function

(2012) Hyejung Won et al.   NATURE

Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice

(2012) Sheryl S. Moy et al.   NEUROTOXICOLOGY AND TERATOLOGY

Animal Models of Neuropsychiatric Disorders

(2011) A.B.P. Fernando et al.   Annual Review of Clinical Psychology

Effects of the cognition impairer MK-801 on learning and memory in mice and rats

(2011) F. Josef van der Staay et al.   BEHAVIOURAL BRAIN RESEARCH

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

(2011) M Carlén et al.   MOLECULAR PSYCHIATRY

NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis

(2011) Gary Gilmour et al.   NEUROPHARMACOLOGY

Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour

(2011) Nico Wegener et al.   NEUROSCIENCE LETTERS

Impulsive behaviour induced by both NMDA receptor antagonism and GABAA receptor activation in rat ventromedial prefrontal cortex

(2011) Emily R. Murphy et al.   PSYCHOPHARMACOLOGY

Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior

(2010) J. Blundell et al.   JOURNAL OF NEUROSCIENCE

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

The critical period of valproate exposure to induce autistic symptoms in Sprague–Dawley rats

(2010) Ki Chan Kim et al.   TOXICOLOGY LETTERS

Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice

(2009) Mikhail Kalinichev et al.   BEHAVIOURAL PHARMACOLOGY

Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex

(2009) Dong Xi et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice

(2009) Karen Kumakura et al.   NEUROSCIENCE RESEARCH

N-methyl-d-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder

(2008) V. Jensen et al.   NEUROSCIENCE

Low dose MK-801 reduces social investigation in mice

(2008) H ZOU et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The neuropharmacology of impulsive behaviour

(2008) T PATTIJ et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Domain interplay concept in animal models of neuropsychiatric disorders: A new strategy for high-throughput neurophenotyping research

(2007) A KALUEFF   BEHAVIOURAL BRAIN RESEARCH